Clinical Trial Update: Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing raltegravir to a protease inhibitor in treatment-naïve HIV/Hepatitis C drug users. The update provides no results or status det…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Protease inhibitor (unspecified)
• Raltegravir (raltegravir)

Snippet

Sponsor: St. James's Hospital, Ireland | Conditions: HIV Infections, Hepatitis C | Phase 4 | Status: UNKNOWN